Cargando…
Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases
BACKGROUND: Abatacept is a selective T-cell costimulation modulator approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. Reports were recently published on hepatitis B virus reactivation (HBVr) in patients who were treated with abatacept. Howeve...
Autores principales: | Wang, Jingjing, Zhang, Xin, Geng, Xiaozhen, Shi, Juanjuan, Jia, Xiaoli, Dang, Shuangsuo, Wang, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092962/ https://www.ncbi.nlm.nih.gov/pubmed/35706497 http://dx.doi.org/10.1016/j.eclinm.2022.101425 |
Ejemplares similares
-
Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database
por: Wang, Jingjing, et al.
Publicado: (2022) -
Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients
With Unresectable or Metastatic Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2021) -
Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database
por: Wang, Shuai, et al.
Publicado: (2020) -
A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
por: Wang, Yikai, et al.
Publicado: (2022) -
Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
por: Wang, Wenjun, et al.
Publicado: (2016)